How long does Mounjaro take to work? What to expect, week by week

Appetite effects often start within days of the first injection, though the starter dose is deliberately low.
The 2.5mg first pen is about letting your body settle, not about maximum results.
Steady weight change typically shows over weeks and months as the dose is titrated upward by a prescriber.
In the SURMOUNT-1 trial the largest average reductions were measured at 72 weeks, not in the first month.

Mounjaro usually begins working within the first few days: appetite signals shift almost straight away, and many people notice reduced hunger and smaller portions within the first one to two weeks. Meaningful weight change, however, builds over months as the dose is gradually increased. Mounjaro (tirzepatide) is a prescription-only medicine, so a prescriber assesses whether it suits you before any treatment begins. Below we walk through what actually happens, and when.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

From your first injection to the months ahead: how the timeline actually unfolds

You've just done your first 2.5mg injection — so when should something happen?

Picture the evening after your first pen. It's in the fridge door, the swab's in the bin, and you're wondering whether tomorrow morning you'll feel any different. For a lot of people, the honest answer is: a little. Within the first few days, many notice they're simply less interested in food. Portions that used to feel normal start to feel like too much halfway through.

That early shift happens because tirzepatide acts on two gut-hormone receptors, GIP and GLP-1, that influence appetite and how full you feel, and it slows how quickly your stomach empties. The effect on hunger can register quickly. The effect on the scales is slower, and that gap trips people up.

The first pen is 2.5mg, and its job is adjustment rather than treatment. This starter strength exists to let your system get used to the medicine and to keep early nausea to a minimum, which is why prescribers rarely expect dramatic weight change in month one. If you want the fuller picture of those opening days, we've written separately about how long Mounjaro takes to start working.

So a fair expectation after that first injection: reduced appetite fairly soon, some early digestive niggles that usually settle, and patience on the weight itself. That last part is the hard bit.

How long does it take for Mounjaro to suppress appetite versus shift the scales?

These two things run on different clocks, and confusing them causes a lot of needless worry. The appetite effect is the fast one. People frequently describe feeling full sooner and thinking about food less within the first week or two, sometimes within days. If you'd like the detail on that specifically, see our page on how long Mounjaro takes to suppress appetite.

Weight loss is the slower clock. A reduced appetite has to translate into a sustained calorie deficit over weeks before the scales reflect it meaningfully, and body weight naturally wobbles day to day with hydration, food volume and hormones. Weighing daily in the first fortnight tends to generate anxiety rather than useful information.

A question our prescribers hear most weeks is some version of "my appetite dropped almost immediately, so why hasn't the weight followed?" The reassuring answer is that this sequence is exactly what you'd expect. The appetite change is the mechanism; the weight change is the downstream result, and it lags behind.

Because the starter dose is low, the appetite effect at 2.5mg is often gentler than it becomes on higher strengths. Many people find hunger control deepens as the dose steps up. If early weeks feel underwhelming on the scales, that's usually the timeline working as designed, not a sign the medicine has failed you.

Why the dose steps up gradually, and what that does to your timeline

Mounjaro isn't a fixed dose you stay on from day one. In the UK it comes in six strengths: 2.5, 5, 7.5, 10, 12.5 and 15mg, and treatment starts at 2.5mg before being titrated upward by the prescriber, usually in four-week steps. Each pen holds four weekly doses.

This gradual climb is central to the timeline. The starter strength settles your system and blunts nausea; the therapeutic effect on appetite and weight tends to strengthen as you move to 5mg and beyond. That's why judging the medicine by your first month alone is misleading. You may not reach a dose that's doing its full work for you until several months in, and where you land is an individual clinical decision rather than a target everyone hits.

Titration timing, and whether and when to move up, is always a prescriber's call based on how you're tolerating things, informed by the Patient Information Leaflet. We don't publish a schedule for you to follow because the right pace genuinely varies from person to person. If you're curious how the increases map onto results over time, we cover how long it takes to lose weight on Mounjaro in more depth.

One practical upshot: patience early on is not passive. Tolerating the low doses well is what lets you climb toward the strengths where most of the effect lives. Rushing rarely helps.

What the trial evidence tells us about timing

The clearest picture comes from clinical trials, and it firmly locates the big results in the long term rather than the first weeks. In the SURMOUNT-1 trial, published in the New England Journal of Medicine, adults were followed over 72 weeks, and average body-weight reduction reached roughly 20 to 21% at the 15mg dose, with some analyses higher. That trial randomised thousands of adults, and crucially, those headline figures were measured at the 72-week mark, not month one.

Reading that carefully reframes expectation. The trajectory was a steady decline across more than a year, as participants were titrated up and stayed on treatment, alongside a reduced-calorie diet and increased activity. You can read the underlying data in the SURMOUNT-1 trial published in the New England Journal of Medicine, and the NHS overview of the medicine sits at the NHS page on tirzepatide.

What this means for your own timeline is simple to say and harder to sit with: early weeks establish the habit and settle tolerance; the months that follow are where the numbers accumulate. NICE's own appraisal, which recommends tirzepatide within defined criteria, also builds in a review at six months, reflecting that a meaningful judgement takes that long. If you like seeing typical trajectories laid out, our page on average weight loss on Mounjaro puts the numbers in context, and Mounjaro results covers the wider picture.

The first month specifically: what's normal and what isn't

Month one deserves its own honest account, because it's when most people either lose their nerve or set unfair expectations. On the 2.5mg starter dose, common experiences are reduced appetite, feeling full quickly, and gastrointestinal effects like nausea, mild reflux, constipation or looser stools. These are usually most noticeable after starting or a dose increase, and often settle within days to a couple of weeks.

Weight change in the first month is typically modest and varies widely. Some see a few pounds shift; others see very little movement early and more later. Both are within normal range. A slow start is not a failure of the medicine, and it's rarely a reason to abandon the plan. We've written specifically about the first month on Mounjaro if you want realistic markers.

What isn't routine, and warrants prompt medical attention, is severe, persistent stomach pain that may spread to your back, with or without vomiting. The MHRA issued a Drug Safety Update in January 2026 flagging acute pancreatitis as an infrequent but serious side effect of GLP-1 medicines, and that symptom should never be waited out. Signs of dehydration from severe sickness, or an allergic reaction, also need urgent help.

If early weeks feel harder than expected on the digestive front, the practical support of a prescriber matters. Getting used to Mounjaro is often smoother with someone to talk the side effects through with, rather than guessing alone.

When results slow down, and why that isn't the medicine failing

Later in the journey a different worry appears: the scales stall. After an encouraging run, weight loss often slows or pauses, and it's easy to read that as the treatment giving up. Usually it isn't. As you lose weight your body needs fewer calories, and a plateau can simply reflect a new balance point, sometimes at a dose that hasn't yet been increased.

Plateaus are common enough that we've given them their own page on the Mounjaro plateau, and a related question, why some people find themselves not losing weight on Mounjaro, is worth reading if progress feels stuck. Sometimes the answer involves a prescriber-led dose review; sometimes it's about protein intake, hydration, fibre and activity, which matter more as appetite falls.

It also helps to remember the licensed context. Mounjaro is intended for weight management alongside a reduced-calorie diet and increased activity, not instead of them. The medicine makes the deficit easier to sustain; it doesn't replace the deficit. NICE's guidance builds in a six-month review point precisely so that response can be judged fairly rather than week by week.

None of this means you're doing something wrong when the pace changes. Weight is shaped by biology, and a treatment timeline is rarely a straight line down. Understanding how the medicine behaves over the longer term, including how long people typically stay on Mounjaro, tends to make the slower stretches less alarming.

How your route to treatment affects how quickly you can start

There's a second sense of "how long" worth answering: not how fast the medicine works, but how quickly you can begin at all, done safely. In the UK the only legal route to Mounjaro is a prescription following a clinical assessment, because it's a prescription-only medicine and a prescriber must decide it suits you.

At nume, the consultation is free, and a named GPhC-registered Independent Prescriber reads your answers the same day, not an algorithm. If treatment is clinically approved and you order before 12pm on a working day, it's dispatched the same day from our GPhC-registered UK pharmacy and delivered free the next working day by DPD, tracked, in plain packaging. So the practical wait to start, once you're assessed and suitable, is short. The medicine's timeline then unfolds as above.

Eligibility for private treatment follows the licence: adults with a BMI of 30 or above, or 27 or above with a weight-related condition such as high blood pressure, high cholesterol, prediabetes or sleep apnoea. Thresholds are set 2.5 kg/m² lower for people of South Asian, Chinese, Middle Eastern, Black African or African-Caribbean backgrounds under UK guidance. It isn't recommended in pregnancy, when breastfeeding or trying to conceive, and it isn't licensed for under-18s. You can read more about our clinical oversight on our page about our clinical team, or explore the weight-loss treatment options we offer.

Related questions we've answered

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions